This article analyzes how AI product owners in healthcare balance innovation with accountability, using real-world examples like FDA clearances and Epic integrations to ensure patient safety and ethic...
Recent research highlights how neutrophil extracellular traps (NETs) drive chronic inflammation and vascular aging, with NET inhibitors like DNase I and PAD4 antagonists showing potential in reducing ...
The shift from stem cell transplants to extracellular vesicles offers enhanced stability, easier storage, and scalable production, potentially improving treatment accessibility for conditions like Alz...
Recent research shows neutrophil extracellular traps accelerate vascular aging by promoting inflammation and endothelial damage, with NET inhibitors offering promising anti-aging therapies for cardiov...
Extracellular vesicles from stem cells offer a safer alternative to transplants for Alzheimer’s and Parkinson’s, reducing neuroinflammation and promoting repair with promising preclinical ...
Excessive neutrophil extracellular traps (NETs) promote chronic inflammation and endothelial dysfunction, increasing risks for atherosclerosis and stroke, with recent research highlighting inhibitors ...
Recent research reveals osteoarthritis patients face a 25% higher risk of neurodegenerative diseases due to chronic inflammation, with practical strategies like diet and exercise offering protection. ...
Recent breakthroughs in cancer therapy, including Leo Cancer Care’s proton chair and Moderna’s mRNA vaccines, reduce side effects and improve survival, empowering patients with early detec...
The AI scribe market is booming, with startups like Heidi Health and Abridge reducing physician burnout and improving efficiency, while facing competition from Epic and challenges from AI giants and r...
Artificial intelligence is accelerating drug discovery for rare diseases, reducing costs by up to 50% and shortening timelines, enabling bespoke therapies and improving healthcare equity globally. AI ...
